How Diagnosio Revolutionizes Diagnostics

In the rapidly evolving world of AI healthcare, BraineHealth’s Diagnosio stands out as a game-changer, powered by our groundbreaking US Patent 11,908,579 B2. This innovation flips traditional diagnostics on its head with inversion technology, which doesn’t just analyze symptoms—it recommends the optimal next step to maximize accuracy and efficiency.

At its core, Diagnosio uses neural network-driven probabilistic optimizations to achieve 99% classification accuracy in simulations, as validated by a 2018 KTH Royal Institute of Technology thesis. Imagine a virtual doctor that evaluates thousands of possibilities, scaling to over 20,000 cases and 200,000 observables. Unlike competitors like Microsoft’s MAI-DxO, which focus on forward prediction, Diagnosio’s dynamic decision-making ensures smarter, faster outcomes, reducing costs and improving patient care.

Recent media coverage in BizWeekly.com highlights our visionary journey: “The Founder Who Built a Virtual Doctor Before AI Was Cool.” Similarly, AP notes our patent’s global potential, emphasizing its role in tackling healthcare challenges. This technology extends beyond medicine to finance risk assessments and engineering troubleshooting, opening doors for cross-industry applications.

Ready to integrate this transformative AI? Explore licensing opportunities via Vibrant IP or contact us today to discuss partnerships.

License the Patent | Contact Us